维普中文期刊产品整合服务

Characterization of a Novel Anti-DR5 Monoclonal Antibody WD1 with the Potential to Induce Tumor Cell Apoptosis

查看全文 作　　者：Jing [1,2,3]Wang;Zhou [2,3]Lin;Chunxia [2]Qiao;Ming [2]Lv;Ming [2]Yu;He [2]Xiao;Qingyang [2]Wang;Liyan [2]Wang;Jiannan [2]Feng;Beifen [1,2]Shen;Yuanfang [1]Ma;Yan [1,2]Li 高影响力作者 机构地区：[1]Laboratory of Cellular and Molecular Immunology, Institute of Immunology, Henan University, Kaifeng, China;[2]Institute of Basic Medical Sciences, Beijing, China;[3]These authors contributed equally to this work高影响力机构 出　　处：《Cellular & Molecular Immunology》索引2008年第5卷第1期,共6页高影响力期刊 摘　　要：TNF-related apoptosis-inducing ligand (TRAIL) is a TNF family member capable of inducing apoptosis. Death receptor 5 (DR 5) is a key receptor of TRAIL and plays an important role in TRAIL-induced apoptosis. To prepare monoclonal antibodies (mAbs) against DR5,cDNA encoding soluble DR5 (sDR5) was firstly amplified by reverse transcriptase-polymerase chain reaction (RT-PCR) with specific primers,and then inserted into a prokaryotic expression vector pET-30a. The recombinant plasmid was expressed in Escherichia coli strain BL21 (DE3),and sDR5 was purified by nickel affinity chromatography. As an antigen,sDR5 was used to immunize mice. Hybridomas secreting antibodies against sDR5 were identified. One positive clone was selected to produce antibody,WD1. ELISA and immunofluorescence demonstrated that WD1 could bind recombinant sDR5 and membrane-bound DR5 (mDR5) on Jurkat and Molt-4 cells. ATPLite assays showed that Jurkat and Molt-4 cells were sensitive to the antibody in a dose dependent manner. The Annexin V/PI assays and Giemsa's staining both showed that WD1 could induce Jurkat cell apoptosis efficiently. Transient transfection of 293T cells and indirect immunofluorescence assay demonstrated that mAb (WD1) couldn't cross-react with DR4. Our findings indicated that the novel antibody,WD1 could act as a direct agonist,bind DR5 characteristically,and initiate efficient apoptotic signaling and tumor regression. Thus,WD1 would be a leading candidate for potential cancer therapeutics. 关 键 词：单克隆抗体 药物 细胞 免疫系统
相关文献

参考文献(11)

引证文献(4)

耦合文献(32)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费